Kriya Therapeutics Patents – Insights & Stats (Updated 2023)

Kriya Therapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 90% patents are active. Canada is where Kriya Therapeutics has filed the maximum number of patents, followed by Australia and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kriya Therapeutics.

Kriya Therapeutics was founded in the year 2019. Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Do read about some of the most popular patents of Kriya Therapeutics which have been covered by us in this article and also you can find Kriya Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kriya Therapeutics patent portfolio.

How many patents does the founder and the CEO of Kriya Therapeutics have?

The founder Fraser Wright has 0 patent and Roger Jeffs has 0 patent and CEO Shankar Ramaswamy has 1 patent.

How many patents does Kriya Therapeutics have?

Kriya Therapeutics has a total of 20 patents globally. These patents belong to 6 unique patent families. Out of 20 patents, 18 patents are active.

How Many Patents did Kriya Therapeutics File Every Year?

Kriya Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKriya Therapeutics Applications FiledKriya Therapeutics Patents Granted
20234
20226
202110

How many Kriya Therapeutics patents are Alive/Dead?

Kriya Therapeutics Patent Portfolio

 How Many Patents did Kriya Therapeutics File in Different Countries?

Kriya Therapeutics Worldwide Patent Trend

Countries in which Kriya Therapeutics Filed Patents

CountryPatents
Canada3
Australia2
Europe2
New Zealand1
Mexico1
Brazil1
United States Of America1
South Africa1
Hong Kong (S.A.R.)1
Israel1

Where are Research Centres of Kriya Therapeutics Patents Located?

The Research Centre for all the Kriya Therapeutics patents is the United States of America.

What Percentage of Kriya Therapeutics US Patent Applications were Granted?

Kriya Therapeutics (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Kriya Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Kriya Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Sterne Kessler Goldstein & Fox10%

List of Kriya Therapeutics Patents

Kriya Therapeutics PatentsTitle
US20220162638A1Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancer
EP4228610A1Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancer
EP4176060A2Modified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
WO2023133561A1Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-Igf-1R Antibodies And Methods Of Using The Same
WO2022221462A1Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Vlcad Or Mcad And Methods Of Using The Same
WO2022187679A1Viral Vector Constructs Incorporating Dna For Inhibiting Toll Like Receptors And Methods Of Using The Same
WO2022164923A1Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-Tnf Antibodies And Methods Of Using The Same
CA3206107A1Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-Tnf Antibodies And Methods Of Using The Same
CA3173768A1Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancer
CA3174156A1Modified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
AU2022214822A1Vector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-Tnf Antibodies And Methods Of Using The Same
AU2021300450A1Modified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
BR112022026776A2Modified Insulin And Glucokinase Nucleic Acids For The Treatment Of Diabetes
HK40084767AModified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
IL299545AModified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
MX2023000099AModified Insulin And Glucokinase Nucleic Acids For The Treatment Of Diabetes
NZ802339AVector Constructs For Delivery Of Nucleic Acids Encoding Therapeutic Anti-Tnf Antibodies And Methods Of Using The Same
ZA202300430AModified Insulin And Glucokinase Nucleic Acids For Treating Diabetes
WO2022081776A1Viral Vector Constructs For Delivery Of Nucleic Acids Encoding Cytokines And Uses Thereof For Treating Cancer
WO2022006551A3Modified Insulin And Glucokinase Nucleic Acids For Treating Diabetes

What are Kriya Therapeutics key innovation segments?

What Technologies are Covered by Kriya Therapeutics?

The chart below distributes patents filed by Kriya Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Kriya Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kriya Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kriya Therapeutics?

Leave a Comment

Table of Content

Popular Topics

Insights you may find interesting